(Photo Courtesy: www.gptuae.com)
During this time, it produced a number of medicines, for both domestic and international markets.
Practically there was no production activity at the plant since 2013. Hence the company announced its decision to shut it down by 2016.
The closure, according to Pfizer, will not impact the supply of any of its medicines, it told BioSpectrum in an email.
The facility employed 212 professionals and the company had offered a generous voluntary retirement scheme (VRS) to the workmen last year upon their request, said Pfizer.
The VRS has been taken up by as many as 132 employees out of the 212 workmen.